|  | Category a |  | P value |
---|---|---|---|---|
 | 1 No. (%) | 2 No. (%) | 3 No. (%) | |
Group | 42 | 25 | 43 | Â |
Malignant | 0 (0.0) | 25 (59.5) | 17 (40.5) | <0.001 |
Probable malignantb | 19 (59.4) | 0 (0.0) | 13 (40.6) | Â |
Benign | 23 (63.9) | 0 (0.0) | 13 (36.1) | Â |
Fluid | Â | Â | Â | Â |
Ascites | 19 (50.0) | 8 (21.1) | 11 (28.9) | 0.155 |
Pleural effusion | 23 (31.9) | 17 (23.6) | 32 (44.4) | Â |
Cytology result | Â | Â | Â | Â |
Positive | 0 (0.0) | 25 (59.5) | 17 (40.5) | <0.001 |
Negative | 42 (61.8) | 0 (0.0) | 26 (38.2) | Â |
Etiology (cancer) | Â | Â | Â | Â |
Breast | 2 (33.3) | 2 (33.3) | 2 (33.3) | <0.001 |
Colon | 9 (60.0) | 1 (6.7) | 5 (33.3) | Â |
Lung | 4 (15.4) | 11 (42.3) | 11 (42.3) | Â |
Ovary | 0 (0.0) | 9 (60.0) | 6 (40.0) | Â |
Others | 4 (30.8) | 2 (15.4) | 7 (53.8) | Â |
Etiology | Â | Â | Â | Â |
Heart failure | 5 (55.6) | 0 (0.0) | 4 (44.4) | 0.002 |
Liver cirrhosis | 13 (81.3) | 0 (0.0) | 3 (18.8) | Â |
Inflammatory | 5 (50.0) | 0 (0.0) | 5 (50.0) | Â |